Engaging patients in a life-long partnership to advance science
57,000 Total Participants and Counting
The Michigan Genomics Initiative (MGI) is creating an institutional repository of DNA and genetic data together with a rich medical phenotype for broad portfolio of future medical research.
Using a modern, opt-in, patient-centric informed consent model, participants are enrolled in MGI to contribute biospecimens for genotyping, electronic health record (EHR) data for clinical information, patient reported questionnaires for pain, mood, affect, and function, and linkages to local and national data sources. Using an innovative graphical consent document, each participant understands that they may be re-contacted in the future for follow up studies if they have a genotype or clinical condition of interest to researchers. MGI is committed to advancing the understanding health and wellness, the development of disease, predicting the response to treatments, and advancing drug development.